Current through Register Vol. 24-24, December 15, 2024
Except as provided in WAC 246-240-078, the licensee shall
require the authorized nuclear pharmacist to be a pharmacist who:
(1) Is certified by a specialty board whose
certification process has been recognized by the department, NRC, or an
agreement state. The names of board certifications that have been recognized by
the department, NRC, or an agreement state are posted on the NRC's medical uses
licensee toolkit web page. To have its certification process recognized, a
specialty board shall require all candidates for certification to:
(a) Have graduated from a pharmacy program
accredited by the Accreditation Council for Pharmacy Education (ACPE) or have
passed the Foreign Pharmacy Graduate Examination Committee (FPGEC)
examination;
(b) Hold a current,
active license to practice pharmacy;
(c) Provide evidence of having acquired at
least 4,000 hours of training/experience in nuclear pharmacy practice. Academic
training may be substituted for no more than 2,000 hours of the required
training and experience; and
(d)
Pass an examination in nuclear pharmacy administered by dip-lomates of the
specialty board, which assesses knowledge and competency in procurement,
compounding, quality assurance, dispensing, distribution, health and safety,
radiation safety, provision of information and consultation, monitoring patient
outcomes, research and development; or
(2)
(a) Has
completed 700 hours in a structured educational program consisting of both:
(i) Two hundred hours of classroom and
laboratory training in the following areas:
(A) Radiation physics and
instrumentation;
(B) Radiation
protection;
(C) Mathematics
pertaining to the use and measurement of radioactivity;
(D) Chemistry of radioactive material for
medical use; and
(E) Radiation
biology; and
(ii)
Supervised practical experience in a nuclear pharmacy involving:
(A) Shipping, receiving, and performing
related radiation surveys;
(B)
Using and performing checks for proper operation of instruments used to
determine the activity of dosages, survey meters, and, if appropriate,
instruments used to measure alpha-or beta-emitting radionuclides;
(C) Calculating, assaying, and safely
preparing dosages for patients or human research subjects;
(D) Using administrative controls to avoid
medical events in the administration of radioactive material; and
(E) Using procedures to prevent or minimize
radioactive contamination and using proper decontamination procedures;
and
(b) Has
obtained written attestation, signed by a preceptor authorized nuclear
pharmacist, that the individual has satisfactorily completed the requirements
in (a) of this subsection and is able to independently fulfill the radiation
safety related duties as an authorized nuclear pharmacist.
Statutory Authority:
RCW
70.98.050. 11-03-068, § 246-240-075,
filed 1/18/11, effective 2/18/11; 06-05-019, § 246-240-075, filed 2/6/06,
effective 3/9/06.
